Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Hubner

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Plos One|October 19, 2018
The HER3 pathway as a potential target for inhibition in patients with biliary tract cancersAngela Lamarca, Salvatore Galdy, Jorge Barriuso, et al.
BMJ Open|May 14, 2021
Prospective observational study of prevalence, assessment and treatment of pancreatic exocrine insufficiency in patients with inoperable pancreatic malignancy (PANcreatic cancer Dietary Assessment (PanDA): a study protocolLindsay E Carnie, Angela Lamarca, Kate Vaughan, et al.
Neuroendocrinology|February 1, 2019
Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine CarcinomasMelissa Frizziero, Francesca Spada, Angela Lamarca, et al.
Pancreas|December 3, 2021
Pancreatic Enzyme Replacement Therapy for Patients Diagnosed With Pancreaticobiliary Cancer: Validation of an Algorithm for Dose Escalation and ManagementLindsay E Carnie, Kelly Farrell, Natalie Barratt, et al.
Oncotarget|March 31, 2018
PD-L1 expression and presence of TILs in small intestinal neuroendocrine tumoursAngela Lamarca, Daisuke Nonaka, Wolfgang Breitwieser, et al.
Cancer Treatment Reviews|March 17, 2021
Knowns and unknowns of bone metastases in patients with neuroendocrine neoplasms: A systematic review and meta-analysisEsmeralda Garcia-Torralba, Francesca Spada, Kok Haw Jonathan Lim, et al.
Journal of the National Cancer Institute|January 29, 2017
Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine CarcinomasAngela Lamarca, Thomas Walter, Marianne Pavel, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2021
Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre studyGiuseppe Curigliano, Miguel Martin, Komal Jhaveri, et al.
British Journal of Cancer|April 28, 2022
Intrahepatic cholangiocarcinoma hidden within cancer of unknown primaryAlicia-Marie Conway, Georgina C Morris, Sarah Smith, et al.
Cancers|May 16, 2023
Prospective Observational Study of Prevalence, Assessment and Treatment of Pancreatic Exocrine Insufficiency in Patients with Inoperable Pancreatic Malignancy (PANcreatic Cancer Dietary Assessment-PanDA)Lindsay E Carnie, Dinakshi Shah, Kate Vaughan, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Plos One|October 19, 2018
The HER3 pathway as a potential target for inhibition in patients with biliary tract cancersAngela Lamarca, Salvatore Galdy, Jorge Barriuso, et al.
BMJ Open|May 14, 2021
Prospective observational study of prevalence, assessment and treatment of pancreatic exocrine insufficiency in patients with inoperable pancreatic malignancy (PANcreatic cancer Dietary Assessment (PanDA): a study protocolLindsay E Carnie, Angela Lamarca, Kate Vaughan, et al.
Neuroendocrinology|February 1, 2019
Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine CarcinomasMelissa Frizziero, Francesca Spada, Angela Lamarca, et al.
Pancreas|December 3, 2021
Pancreatic Enzyme Replacement Therapy for Patients Diagnosed With Pancreaticobiliary Cancer: Validation of an Algorithm for Dose Escalation and ManagementLindsay E Carnie, Kelly Farrell, Natalie Barratt, et al.
Oncotarget|March 31, 2018
PD-L1 expression and presence of TILs in small intestinal neuroendocrine tumoursAngela Lamarca, Daisuke Nonaka, Wolfgang Breitwieser, et al.
Cancer Treatment Reviews|March 17, 2021
Knowns and unknowns of bone metastases in patients with neuroendocrine neoplasms: A systematic review and meta-analysisEsmeralda Garcia-Torralba, Francesca Spada, Kok Haw Jonathan Lim, et al.
Journal of the National Cancer Institute|January 29, 2017
Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine CarcinomasAngela Lamarca, Thomas Walter, Marianne Pavel, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2021
Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre studyGiuseppe Curigliano, Miguel Martin, Komal Jhaveri, et al.
British Journal of Cancer|April 28, 2022
Intrahepatic cholangiocarcinoma hidden within cancer of unknown primaryAlicia-Marie Conway, Georgina C Morris, Sarah Smith, et al.
Cancers|May 16, 2023
Prospective Observational Study of Prevalence, Assessment and Treatment of Pancreatic Exocrine Insufficiency in Patients with Inoperable Pancreatic Malignancy (PANcreatic Cancer Dietary Assessment-PanDA)Lindsay E Carnie, Dinakshi Shah, Kate Vaughan, et al.
Pageof 11